Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas
Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas
Active, not recruiting · NCT05400109 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Active, not recruiting | Phase 1 | 2026-05-05 | NCT05400109 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| David Wald | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center | Cleveland | United States | 20 |
| University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center | Cleveland | United States | 13 |
| University of Iowa/Holden Comprehensive Cancer Center | Iowa City | United States | 197 |